LECAP Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,701
Closed -$2.36M 338
2024
Q4
$2.36M Buy
5,701
+4,872
+588% +$2.14M 0.64% 40
2024
Q3
$419K Buy
+829
New +$403K 0.09% 273
2024
Q1
Sell
-1,309
Closed -$727K 336
2023
Q4
$727K Buy
+1,309
New +$615K 0.26% 147

Other funds holding IDXX

LECAP Asset Management's IDXX Position: Q1 2025 in Review

LECAP Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 5,701 shares — an estimated $2.36M sold.

LECAP Asset Management first reported a position in IDXX in Q4 2023 and held it in 3 quarters. The position peaked at $2.36M in Q4 2024. 1,144 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • LECAP Asset Management reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • LECAP Asset Management sold 5,701 Idexx Laboratories shares in Q1 2025, an estimated $2.36M.
  • LECAP Asset Management first reported a position in Idexx Laboratories in Q4 2023 and held it in 3 quarters.
  • LECAP Asset Management's Idexx Laboratories position peaked at $2.36M in Q4 2024.
  • 1,144 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on LECAP Asset Management's 13F filing for Q1 2025, filed 23 Apr 2025.